Press releases
Some non-regulatory announcements are only available in English. All announcements required under applicable law, regulation or code are available in English and Swedish.
2026
28 Apr 2026, 08:00 | Regulatory
Lund, Sweden April 28, 2026, Hansa Biopharma AB (publ), Reg. No. 556734-5359 (“Hansa Biopharma”), with registered office in Lund, gives notice to Annual General Meeting to be held on Monday June 1, 2026 at 14:30 CEST, Elite Hotel Ideon, Scheelevägen 27, SE-223 63 Lund. Registration starts at 14:00 CEST.
23 Apr 2026, 07:00 | Regulatory
· PDUFA target date set for December 19 by the FDA
· Runway significantly extended
8 Apr 2026, 17:00
26 Mar 2026, 07:00 | Regulatory
20 Mar 2026, 08:00 | Regulatory
Lund, Sweden, March 20, 2026. Hansa Biopharma AB (publ) (Nasdaq Stockholm: HNSA) (“Hansa” or the “Company”) today announces that it has entered into a U.S. convertible note purchase agreement with certain funds managed by Athyrium Capital Management (“Athyrium”), comprising USD 30 million aggregate principal amount of unsecured convertible senior notes (the “Financing”). The Fi…
13 Mar 2026, 12:10
10 Mar 2026, 10:15
9 Mar 2026, 09:55